Vitro Biopharma Announces Changes in SEC Registration

Golden, Colorado-October 13, 2020 Vitro Diagnostics, Inc. (OTCQB: VODG), dba Vitro Biopharma announced the revocation of its SEC registration for Vitro Diagnostics, Inc while also announcing its plans for re-registration with the SEC. As noted in our prior releases,...
Vitro Biopharma Announces MaloneBailey L.L.P. as its new Auditors

Vitro Biopharma Announces MaloneBailey L.L.P. as its new Auditors

Golden, Colorado-July20th, 2020-Vitro Diagnostics, Inc. (OTCQB: VODG), dba Vitro Biopharma, announced that it has engaged MaloneBailey L.L.P. (Certified Public Accounting Firm www.malonebailey.com ) as its new auditors that will be auditing the company’s consolidated...
Vitro Biopharma Receives Recognition from BioInformant

Vitro Biopharma Receives Recognition from BioInformant

Coronavirus disease (COVID-19) is an emerging global pandemic that is threatening the viability of healthcare systems worldwide. The virus responsible for the disease is also known as severe acute respiratory syndrome coronavirus 2 and abbreviated as SARS-CoV-2. The...

Vitro Biopharma First Quarter 2020 Financial Results of Operations

Golden, Colorado-March 26, 2020- Vitro Diagnostics, Inc. (OTCPK: VODG), dba Vitro Biopharma, announced its 1st quarter ended January 31st, 2020 financial results of operations. Vitro Diagnostics Inc. (“Vitro Biopharma”) is pleased to announce a record 1st comparative...